asa guidelines for glp-1 drugs Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement Glucagon‐like peptide‐1 receptor agonists: a

Limited to pregnancies with available data on the presence or absence of a birth defect, including 117 live births, 7 terminated pregnancies and 3 stillbirths

The risk of MACE was also significantly reduced in consecutive studies (Harmony Outcomes [18], REWIND [19], AMPLITUDE-O [20])

Glycemic control can be determined through frequent monitoring of blood glucose, but in practice it is determined by measuring HbA1c , or the percentage of glycated hemoglobin

If symptoms are genuinely anxiety-related rather than medication side effects, they typically persist beyond the immediate post-injection period and occur independently of blood glucose levels or gastrointestinal symptoms